Global Preimplantation Genetic Testing Market Size & Outlook

The global preimplantation genetic testing market size was estimated at USD 852.4 million in 2024 and is projected to reach USD 1,282.1 million by 2030, growing at a CAGR of 7.1% from 2025 to 2030.
Revenue, 2024 (US$M)
$852.4
Forecast, 2030 (US$M)
$1,282.1
CAGR, 2025 - 2030
7.1%
Report Coverage
Worldwide

Global preimplantation genetic testing market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Global preimplantation genetic testing market highlights

  • The global preimplantation genetic testing market generated a revenue of USD 800.7 million in 2023 and is expected to reach USD 1,282.1 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 7% by 2030.
  • In terms of segment, pgd accounted for a revenue of USD 617.2 million in 2023.
  • PGD is the most lucrative procedure type segment registering the fastest growth during the forecast period.
  • In terms of region, Europe was the largest revenue generating market in 2023.
  • Country-wise, Argentina is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 800.7 million
Market revenue in 2030USD 1,282.1 million
Growth rate7% (CAGR from 2023 to 2030)
Largest segmentPgd
Fastest growing segmentPGD
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPGD, PGS

Other key industry trends

  • In terms of revenue, the North America accounted for 23.8% of the global preimplantation genetic testing market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Argentina is the fastest growing regional market and is projected to reach USD 1.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Preimplantation Genetic Testing Market Companies

Name Profile # Employees HQ Website
Bioarray View profile 11-50 Elche, Comunidad Valenciana, Spain, Europe https://bioarray.es
Genea Biomedx View profile 101-250 Sydney, New South Wales, Australia, Oceania https://www.geneabiomedx.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Invitae Corp View profile 1700 1400 16th Street, San Francisco, CA, United States, 94103 https://www.invitae.com
The Cooper Companies Inc View profile 15000 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, United States, 94583 https://www.coopercos.com
Natera Inc View profile 3293 13011 McCallen Pass, Building A Suite 100, Austin, TX, United States, 78753 https://www.natera.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Vitrolife AB ADR View profile 1116 Box 9080, Gothenburg, Sweden, 400 92 https://www.vitrolife.com

Global preimplantation genetic testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preimplantation genetic testing market will help companies and investors design strategic landscapes.


Pgd was the largest segment with a revenue share of 77.08% in 2024. Horizon Databook has segmented the Global preimplantation genetic testing market based on pgd, pgs covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Preimplantation Genetic Testing Procedure Type Outlook (Revenue, USD Million, 2018-2030)
    • PGD
    • PGS
  • Global Preimplantation Genetic Testing Product & Service Outlook (Revenue, USD Million, 2018-2030)
    • Reagents and Consumables
    • Instruments
    • Software
  • Global Preimplantation Genetic Testing Technology Outlook (Revenue, USD Million, 2018-2030)
    • Next Generation Sequencing (NGS)
    • Polymerase Chain Reaction (PCR)
    • Fluorescent In-Situ Hybridization (FISH)
    • Others Technology
  • Global Preimplantation Genetic Testing Application Outlook (Revenue, USD Million, 2018-2030)
    • Chromosomal Abnormalities
    • X-linked Diseases
    • Embryo Testing
    • Aneuploidy screening
    • HLA Typing
    • Other Applications
  • Global Preimplantation Genetic Testing End Use Outlook (Revenue, USD Million, 2018-2030)
    • Fertility Centers
    • Hospitals
    • Diagnostic Centers
    • Research Centers and Academic Labs

Reasons to subscribe to Global preimplantation genetic testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global preimplantation genetic testing market databook

  • Our clientele includes a mix of preimplantation genetic testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global preimplantation genetic testing market , including forecasts for subscribers. This global databook contains high-level insights into Global preimplantation genetic testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global preimplantation genetic testing market size, by regions, 2018-2030 (US$M)

Top 10 countries: Preimplantation genetic testing market size, 2024 (US$M)

Global preimplantation genetic testing market share, by procedure type, 2024 & 2030 (%, US$M)

Preimplantation genetic testing market: Opportunity assessment by country

Global preimplantation genetic testing market, by region, 2024 (US$M)

Global preimplantation genetic testing market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online